The Molecular Basis of Lynch-like Syndrome

[1]  S. Neuhausen,et al.  The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes , 2018, Familial Cancer.

[2]  A. Valencia,et al.  Elucidating the molecular basis of MSH2‐deficient tumors by combined germline and somatic analysis , 2017, International journal of cancer.

[3]  E. Vilar,et al.  Identification of MSH2 inversion of exons 1–7 in clinical evaluation of families with suspected Lynch syndrome , 2017, Familial Cancer.

[4]  P. Goodfellow,et al.  Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer , 2017, JAMA oncology.

[5]  Diarmuid P. O'Donoghue,et al.  Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers , 2017, Cancer medicine.

[6]  Hajime Uno,et al.  Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Y. Okazaki,et al.  Prevalence of Lynch syndrome and Lynch‐like syndrome among patients with colorectal cancer in a Japanese hospital‐based population , 2016, Japanese journal of clinical oncology.

[8]  M. A. Sloane,et al.  Pathogenic germline MCM9 variants are rare in Australian Lynch-like syndrome patients. , 2016, Cancer genetics.

[9]  Å. Borg,et al.  Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing , 2016, Familial Cancer.

[10]  P. Devilee,et al.  Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients , 2016, PloS one.

[11]  M. A. Sloane,et al.  Understanding the Pathogenicity of Noncoding Mismatch Repair Gene Promoter Variants in Lynch Syndrome , 2016, Human mutation.

[12]  Julie O. Culver,et al.  Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort. , 2016, Cancer genetics.

[13]  Lincoln D. Stein,et al.  Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer. , 2016, Cancer letters.

[14]  Wendy K Chung,et al.  Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing , 2015, Genetics in Medicine.

[15]  P. Devilee,et al.  Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers , 2015, European Journal of Human Genetics.

[16]  V. Meiner,et al.  Mutated MCM9 is associated with predisposition to hereditary mixed polyposis and colorectal cancer in addition to primary ovarian failure. , 2015, Cancer genetics.

[17]  R. Pai,et al.  Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome. , 2015, Human pathology.

[18]  M. Senthil,et al.  Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome , 2015, The American surgeon.

[19]  J. R. Hutchins,et al.  MCM9 Is Required for Mammalian DNA Mismatch Repair. , 2015, Molecular cell.

[20]  S. Syngal,et al.  Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome. , 2015, Gastroenterology.

[21]  A. Valencia,et al.  Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair. , 2015, Gastroenterology.

[22]  D. Chang,et al.  Lynch‐like syndrome: Characterization and comparison with EPCAM deletion carriers , 2015, International journal of cancer.

[23]  Hiroyuki Yamamoto,et al.  Microsatellite instability: an update , 2015, Archives of Toxicology.

[24]  Roland Arnold,et al.  Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers , 2015, Nature Genetics.

[25]  Randall W Burt,et al.  ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes , 2015, The American Journal of Gastroenterology.

[26]  P. Goodfellow,et al.  Polymerase ɛ (POLE) mutations in endometrial cancer: Clinical outcomes and implications for Lynch syndrome testing , 2015, Cancer.

[27]  P. Broderick,et al.  Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  W. Frankel,et al.  Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. , 2014, Gastroenterology.

[29]  E. Kuipers,et al.  Somatic aberrations of mismatch repair genes as a cause of microsatellite‐unstable cancers , 2014, The Journal of pathology.

[30]  H. Morreau,et al.  Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer , 2014, European Journal of Human Genetics.

[31]  Aung Ko Win,et al.  Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome) , 2014, The application of clinical genetics.

[32]  I. Chirivella,et al.  Prevalence of germline MUTYH mutations among Lynch-like syndrome patients. , 2014, European journal of cancer.

[33]  Y. Chung,et al.  Frameshift mutation of a histone methylation-related gene SETD1B and its regional heterogeneity in gastric and colorectal cancers with high microsatellite instability. , 2014, Human pathology.

[34]  C. Lázaro,et al.  New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis. , 2014, Human molecular genetics.

[35]  C. Boland,et al.  Inversion of exons 1–7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population , 2014, Familial Cancer.

[36]  Aung Ko Win,et al.  Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. , 2014, Gastroenterology.

[37]  Tina Pesaran,et al.  Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients , 2014, Genetics in Medicine.

[38]  X. Puente,et al.  Exome sequencing identifies MUTYH mutations in a family with colorectal cancer and an atypical phenotype , 2014, Gut.

[39]  T. Pal,et al.  Panel-based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory , 2014, Clinical genetics.

[40]  Aung Ko Win,et al.  Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives , 2014, Gut.

[41]  I. Nagtegaal,et al.  Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. , 2014, Gastroenterology.

[42]  A. Chapelle,et al.  Biallelic MUTYH mutations can mimic Lynch syndrome , 2014, European Journal of Human Genetics.

[43]  A. Naccarati,et al.  Molecular characteristics of mismatch repair genes in sporadic colorectal tumors in Czech patients , 2014, BMC Medical Genetics.

[44]  J. Cubiella,et al.  Prevalence and Characteristics of MUTYH-Associated Polyposis in Patients with Multiple Adenomatous and Serrated Polyps , 2014, Clinical Cancer Research.

[45]  Rodney J Scott,et al.  Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database , 2013, Nature Genetics.

[46]  Charis Eng,et al.  Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study , 2013, British Journal of Cancer.

[47]  L. Vreede,et al.  Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer. , 2013, Gastroenterology.

[48]  W. Zheng,et al.  Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence , 2013, Gut.

[49]  Á. Carracedo,et al.  Risk of cancer in cases of suspected lynch syndrome without germline mutation. , 2013, Gastroenterology.

[50]  P. Williamson,et al.  Colorectal Cancer in a Monoallelic MYH Mutation Carrier , 2013, Journal of Gastrointestinal Surgery.

[51]  Wei Yang,et al.  The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutSα , 2013, Cell.

[52]  F. Coulet,et al.  Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors , 2013, Familial Cancer.

[53]  E. Kampman,et al.  Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps: case-series and literature review , 2013, Familial Cancer.

[54]  Peter Donnelly,et al.  Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2012, Nature Genetics.

[55]  J. Potter,et al.  Identification of Lynch syndrome among patients with colorectal cancer. , 2012, JAMA.

[56]  T. Fukagawa,et al.  Mcm8 and Mcm9 form a complex that functions in homologous recombination repair induced by DNA interstrand crosslinks. , 2012, Molecular cell.

[57]  H. Morreau,et al.  MUTYH-associated polyposis (MAP). , 2011, Critical reviews in oncology/hematology.

[58]  M. Kloor,et al.  Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome , 2011, Journal of Medical Genetics.

[59]  E. Oki,et al.  Concurrent genetic alterations in DNA polymerase proofreading and mismatch repair in human colorectal cancer , 2011, European Journal of Human Genetics.

[60]  J. Hopper,et al.  Mutation deep within an intron of MSH2 causes Lynch syndrome , 2011, Familial Cancer.

[61]  Y. Liu,et al.  Replication error deficient and proficient colorectal cancer gene expression differences caused by 3′UTR polyT sequence deletions , 2010, Proceedings of the National Academy of Sciences.

[62]  D. Amadori,et al.  MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) , 2010, Proceedings of the National Academy of Sciences.

[63]  Aung Ko Win,et al.  A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants , 2010, British Journal of Cancer.

[64]  C. Boland,et al.  MSH6 and MUTYH Deficiency Is a Frequent Event in Early-Onset Colorectal Cancer , 2010, Clinical Cancer Research.

[65]  D. Durocher,et al.  DNA repair has a new FAN1 club. , 2010, Molecular cell.

[66]  W. Bodmer,et al.  MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions , 2010, Familial Cancer.

[67]  Kay Hofmann,et al.  Identification of KIAA1018/FAN1, a DNA Repair Nuclease Recruited to DNA Damage by Monoubiquitinated FANCD2 , 2010, Cell.

[68]  M. Kloor,et al.  Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers. , 2010, Cancer research.

[69]  R. Houlston,et al.  Clinical implications of the colorectal cancer risk associated with MUTYH mutation. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  F. Marchetti,et al.  Heterozygosity for a Bub1 mutation causes female-specific germ cell aneuploidy in mice , 2009, Proceedings of the National Academy of Sciences.

[71]  D. Evans,et al.  Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. , 2009, Gastroenterology.

[72]  Á. Carracedo,et al.  Molecular analysis of the APC and MUTYH genes in Galician and Catalonian FAP families: a different spectrum of mutations? , 2009, BMC Medical Genetics.

[73]  J. Potter,et al.  Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. , 2009, Gastroenterology.

[74]  A. Viel,et al.  Somatic mosaicism in a patient with Lynch syndrome , 2009, American journal of medical genetics. Part A.

[75]  J. Rey,et al.  DNA mismatch repair gene methylation in gastric cancer in individuals from northern Brazil. , 2008, Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al.

[76]  S. Gallinger,et al.  Germline MYH mutations in a clinic‐based series of Canadian multiple colorectal adenoma patients , 2007, Journal of surgical oncology.

[77]  H. Brunner,et al.  Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer , 2007, British Journal of Cancer.

[78]  J. Gisbert,et al.  Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[79]  Ralph Schlapbach,et al.  Characterization of the Interactome of the Human MutL Homologues MLH1, PMS1, and PMS2* , 2007, Journal of Biological Chemistry.

[80]  R. Ward,et al.  The role of MYH and microsatellite instability in the development of sporadic colorectal cancer , 2006, British Journal of Cancer.

[81]  W. Frankel,et al.  Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. , 2006, Cancer research.

[82]  N. Grishin,et al.  Identification of novel restriction endonuclease-like fold families among hypothetical proteins , 2005, Nucleic acids research.

[83]  W. Frankel,et al.  Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). , 2005, The New England journal of medicine.

[84]  Josef Jiricny,et al.  Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. , 2005, Gastroenterology.

[85]  N. Rahman,et al.  Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B , 2004, Nature Genetics.

[86]  S. Thibodeau,et al.  MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. , 2004, Gastroenterology.

[87]  A. Wagner,et al.  A 10‐Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North‐American kindred , 2002, Genes, chromosomes & cancer.

[88]  J. Herman,et al.  Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[89]  P. Broderick,et al.  Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review. , 2017, Gastroenterology.

[90]  M. Greenblatt,et al.  Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program , 2016, Familial Cancer.

[91]  M. A. Sloane,et al.  A cryptic paracentric inversion of MSH2 exons 2-6 causes Lynch syndrome. , 2016, Carcinogenesis.

[92]  P. Laird,et al.  Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. , 2011, The Journal of molecular diagnostics : JMD.

[93]  Suet Yi Leung,et al.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 , 2009, Nature Genetics.